WASHINGTON — The Department of Health and Human Services on Wednesday announced several initiatives to try to reduce reliance on animal testing in drug development.
The Food and Drug Administration released draft guidance meant to help drug companies explore new ways to assess the safety and efficacy of their products without using animals. And the National Institutes of Health said it has offered more than $150 million to institutions working on new research methods that better simulate human biology.
HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the animal testing requirement for monoclonal antibodies. A few months later, the NIH said it would no longer fund research projects that rely solely on animal testing.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
